Vietnam becomes 1st country to authorise commercial circulation of African swine fever vaccine
Vietnam has become the first country in the world to successfully research and produce a vaccine against African swine fever (ASF), and licence its commercial circulation.
NAVET-ASFVAC is manufactured by the Navetco National Veterinary Joint Stock Company (NAVETCO). (Photo: VNA)
Hanoi (VNA) - Vietnam has become the firstcountry in the world to successfully research and produce a vaccine against African swinefever (ASF), and licence its commercial circulation.
The Ministry of Agriculture and Rural Development(MARD) held a ceremony in Hanoi on June 3 to announce the outcomes of the researchand production of the vaccine named NAVET-ASFVAC manufactured by Navetco National VeterinaryJoint Stock Company (NAVETCO).
An African swine fever outbreak was first detected inVietnam in February 2019, and then spread to all 63 provinces and cities nationwide, causing morethan 6 million pigs to be culled.
The disease cost Vietnam over 30 trillion VND (1.29billion USD) in losses, and affected the national consumer price index (CPI) in2020. Currently, it is still reported in many localities nationwide.
Vietnam began working on researching and producingthe vaccine in February 2020 with the help of US experts. Following lab trials,the vaccine has proved to be able to protect at least 80 percent of immunisedpigs, which retain immunity for six months.
The ministry enlisted several scientific councilsand scientists to evaluate its effectiveness.
Last month, an agency representing US scientistssent a letter to Vietnam, affirming that NAVETCO’s vaccine research andevaluation match the results they produced.
The vaccine will first be sold on a small scale andgiven to around 600,000 pigs aged between 8-10 weeks. Following anevaluation, the ministry will consider nationwide distribution.
In his remarks, US Ambassador to Vietnam Marc E. Knapper laudedcooperation between the two countries in addressing such a global issue,stressing that US scientists will continue their cooperation with Vietnam.
At the ceremony, the MARD handed over a licence forcommercial vaccine circulation to NAVETCO.
Apart from NAVETCO, Avac Vietnam One Member Ltd(Avac) and Dabaco Group JSC are also capable to research and produce the ASF vaccine.
Vietnam expects to license two other African swine vaccinesby the end of this year./.
The Dabaco Group Joint Stock Company has said it is striving to announce the result of its project on researching and producing a vaccine against African swine fever (ASF) by the end of this year.
The Ministry of Agriculture and Rural Development (MARD) and the International Finance Corporation (IFC) on December 9 signed a memorandum of understanding on technical support for the prevention and control of African swine fever (ASF) in Vietnam.
Vietnam has successfully produced a vaccine against African swine fever (ASF), said Deputy Minister of Agriculture and Rural Development Phung Duc Tien on June 1.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
NAVET-ASFVAC is manufactured by the Navetco National Veterinary Joint Stock Company (NAVETCO). (Photo: VNA) 
